Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study
J Eur Acad Dermatol Venereol
.
2023 Dec;37(12):e1455-e1457.
doi: 10.1111/jdv.19363.
Epub 2023 Aug 1.
Authors
Hideaki Uchida
1
2
,
Masahiro Kamata
1
,
Takeko Ishikawa
1
,
Makoto Ito
1
,
Ayu Watanabe
1
,
Shota Egawa
1
,
Azusa Hiura
1
,
Saki Fukaya
1
,
Kotaro Hayashi
1
,
Atsuko Fukuyasu
1
,
Takamitsu Tanaka
1
,
Yayoi Tada
1
Affiliations
1
Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
2
Fujimino Kidney Clinic, Saitama, Japan.
PMID:
37467371
DOI:
10.1111/jdv.19363
No abstract available
Publication types
Letter
MeSH terms
Antifungal Agents / adverse effects
Dermatologic Agents*
Humans
Onychomycosis* / drug therapy
Renal Dialysis
Retrospective Studies
Treatment Outcome
Substances
Antifungal Agents
Dermatologic Agents